Allocation of shares in Borregaard to Orkla's primary insiders

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

18 October 2012: Orkla ASA ("Orkla", ticker "ORK") and Borregaard ASA ("Borregaard" or the "Company", ticker "BRG")

With reference to the final results of the initial public offering (the "Offering") in Borregaard announced earlier today and the announcements on primary insiders application for shares in the Offering on 3 October 2012, the following primary insiders of Orkla have been allocated shares at a price of NOK 21 per share in accordance with the procedures and on the terms set out in the prospectus dated 2 October 2012.

  • Canica AS, shareholder in Orkla and closely related party to the chairman of the board Stein Erik Hagen has been allocated 6,600,000 shares in the Offering and will thus own 6,600,000 shares in Borregaard following completion of the Offering. 

  • Ventotene Invest AS, shareholder in Orkla and closely related party to board member Peter A. Ruzicka, has been allocated 15,000 shares in the Offering and will thus own 15,000 shares in Borregaard following completion of the Offering. 

  • Håkon Mageli, Executive Vice President Corporate Communications and Corporate Affairs, has been allocated 14,285 shares in the Offering and will thus own 14,285 shares in Borregaard following completion of the Offering. 

  • Fridthjof Røer, Chief Internal Auditor, has been allocated 8,928 shares in the Offering and will thus own 8,928 shares in Borregaard following completion of the Offering. 

  • Terje Andersen, CFO and current Chairman of the Board in Borregaard ASA has been allocated 3,571 shares in the Offering and will thus own 3,571 shares in Borregaard following completion of the Offering. 

Contact:
Rune Helland, SVP Investor Relations
Tel: +47 22 54 44 11 / +47 97 71 32 50


DISCLAIMERS

These materials are not an offer for sale of securities.

Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures.

The securities have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act.  The Company does not intend to register any part of the offering in the United States or to conduct a public offering of securities in the United States.

Any offering of securities will be made by means of a prospectus that may be obtained from the issuer or selling security holder and that will contain detailed information about the Company and management, as well as financial statements. This document is an advertisement and not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive").  Investors should not subscribe for any securities referred to in this document except on the basis of information contained in the prospectus.

In any EEA Member State other than Norway that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State.

This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) above together being referred to as "relevant persons").  The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons.  Any person who is not a relevant person should not act or rely on this document or any of its contents. 

Stabilization/FSA

 Matters discussed in this release may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe," "expect," "anticipate," "intends," "estimate," "will," "may," "continue," "should" and similar expressions.  The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions.  Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control.  Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements.

--

This information is subject to disclosure under the Norwegian Securities Act section §5-12